REGISTER HERE
Unlike oral medications that require specific meal timing, tirzepatide is administered as a subcutaneous injection and can be given at any time of day, regardless of meals
ATTAIN-2 enrolled over 1,600 adults with type 2 diabetes and showed meaningful weight reductions of 5.1 to 9.6 percent depending on dose, along with significant improvements in blood sugar control and cardiometabolic markers including waist circumference, blood pressure, and cholesterol
Another study using the French National Health Care Insurance System Database also reported increased risks of all thyroid cancers and medullary thyroid cancer with the use of GLP-1RAs (exenatide, liraglutide, and dulaglutide) over 13 years [9]
La inyeccin subcutnea de Mounjaro (tirzepatida 5 mg, 2.5 mg, 5 mg, 7.5 mg, 10 mg y 12.5 mg), solo con receta mdica, no ha sido aprobada por la FDA como segura ni eficaz para tratar la obesidad o el sobrepeso